Highlights of prescribing information of XGEVA (denosumab). Retrieved 20 February 2020, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125320s094lbl.pdf
Adachi Y, Noguchi R, Yoshimatsu Y, Sin Y, Osaki J, Ono T, Iwata S, Akiyama T, Tsuchiya R, Toda Y, Ishihara S, Ogura K, Kobayashi E, Kojima N, Yoshida A, Yokoo H, Kawai A, Kondo T (2024) Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1. Hum Cell 37(3):874–885
Article CAS PubMed Google Scholar
Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Fukushima S, Toda Y, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T (2022) Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone. Hum Cell 35(5):1621–1629
Article CAS PubMed Google Scholar
Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D, Gibbons R, Tirabosco R, O’Donnell P, Flanagan AM (2017) H3F3A (histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. Am J Surg Pathol 41(8):1059–1068
Article PubMed Central PubMed Google Scholar
Anderson JC, Duarte CW, Welaya K, Rohrbach TD, Bredel M, Yang ES, Choradia NV, Thottassery JV, Yancey Gillespie G, Bonner JA, Willey CD (2014) Kinomic exploration of temozolomide and radiation resistance in glioblastoma multiforme xenolines. Radiother Oncol 111(3):468–474
Article CAS PubMed Central PubMed Google Scholar
Anderson SJ, Levin SD, Perlmutter RM (1994) Involvement of the protein tyrosine kinase p56lck in T cell signaling and thymocyte development. Adv Immunol 56:151–178
Article CAS PubMed Google Scholar
Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673–683
Article CAS PubMed Google Scholar
Bairoch A (2018) The Cellosaurus, a cell-Line knowledge resource. J Biomol Tech 29(2):25–38
Article PubMed Central PubMed Google Scholar
Balla P, Moskovszky L, Sapi Z, Forsyth R, Knowles H, Athanasou NA, Szendroi M, Kopper L, Rajnai H, Pinter F, Petak I, Benassi MS, Picci P, Conti A, Krenacs T (2011) Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone. Histopathology 59(3):376–389
Balsas P, Palomero J, Eguileor A, Rodriguez ML, Vegliante MC, Planas-Rigol E, Sureda-Gomez M, Cid MC, Campo E, Amador V (2017) SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. Blood 130(4):501–513
Article CAS PubMed Google Scholar
Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goodie V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR, Campbell PJ, Flanagan AM (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45(12):1479–1482
Article CAS PubMed Google Scholar
Bertoni F, Present D, Sudanese A, Baldini N, Bacchini P, Campanacci M (1988) Giant-cell tumor of bone with pulmonary metastases. Six case reports and a review of the literature. Clin Orthop Relat Res 237:275–285
Bhimani J, Ball K, Stebbing J (2020) Patient-derived xenograft models-the future of personalised cancer treatment. Br J Cancer 122(5):601–602
Article PubMed Central PubMed Google Scholar
Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411(6835):355–365
Article CAS PubMed Google Scholar
Carles F, Bourg S, Meyer C, Bonnet P (2018) PKIDB: a curated, annotated and updated database of protein kinase inhibitors in clinical trials. Molecules 23(4):908
Article PubMed Central PubMed Google Scholar
Casado P, Rodriguez-Prados JC, Cosulich SC, Guichard S, Vanhaesebroeck B, Joel S, Cutillas PR (2013) Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal 6(268):rs6
Do K, Doroshow JH, Kummar S (2013) Wee1 kinase as a target for cancer therapy. Cell Cycle 12(19):3159–3164
Article CAS PubMed Central PubMed Google Scholar
Eckardt JJ, Grogan TJ (1986) Giant cell tumor of bone. Clin Orthop Relat Res 204:45–58
Ekert JE, Johnson K, Strake B, Pardinas J, Jarantow S, Perkinson R, Colter DC (2014) Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro–implication for drug development. PLoS ONE 9(3):e92248
Article PubMed Central PubMed Google Scholar
Fan T, Chen J, Zhang L, Gao P, Hui Y, Xu P, Zhang X, Liu H (2016) Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway. Mol Cancer 15:23
Article PubMed Central PubMed Google Scholar
Ferguson FM, Gray NS (2018) Kinase inhibitors: the road ahead. Nat Rev Drug Discov 17(5):353–377
Article CAS PubMed Google Scholar
Ferrari A, Vincent-Salomon A, Pivot X, Sertier AS, Thomas E, Tonon L, Boyault S, Mulugeta E, Treilleux I, MacGrogan G, Arnould L, Kielbassa J, Le Texier V, Blanche H, Deleuze JF, Jacquemier J, Mathieu MC, Penault-Llorca F, Bibeau F, Mariani O, Mannina C, Pierga JY, Tredan O, Bachelot T, Bonnefoi H, Romieu G, Fumoleau P, Delaloge S, Rios M, Ferrero JM, Tarpin C, Bouteille C, Calvo F, Gut IG, Gut M, Martin S, Nik-Zainal S, Stratton MR, Pauporte I, Saintigny P, Birnbaum D, Viari A, Thomas G (2016) A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers. Nat Commun 7:12222
Article CAS PubMed Central PubMed Google Scholar
Fleuren ED, Zhang L, Wu J, Daly RJ (2016) The kinome “at large” in cancer. Nat Rev Cancer 16(2):83–98
Article CAS PubMed Google Scholar
Goldenberg RR, Campbell CJ, Bonfiglio M (1970) Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am 52(4):619–664
Article CAS PubMed Google Scholar
Hubbard SR, Mohammadi M, Schlessinger J (1998) Autoregulatory mechanisms in protein-tyrosine kinases. J Biol Chem 273(20):11987–11990
Article CAS PubMed Google Scholar
Iorns E, Lord CJ, Grigoriadis A, McDonald S, Fenwick K, Mackay A, Mein CA, Natrajan R, Savage K, Tamber N, Reis-Filho JS, Turner NC, Ashworth A (2009) Integrated functional, gene expression and genomic analysis for the identification of cancer targets. PLoS ONE 4(4):e5120
Article PubMed Central PubMed Google Scholar
Islam S, Wang S, Bowden N, Martin J, Head R (2022) Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target. Br J Clin Pharmacol 88(1):64–74
Article CAS PubMed Google Scholar
Kanojia D, Nagata Y, Garg M, Lee DH, Sato A, Yoshida K, Sato Y, Sanada M, Mayakonda A, Bartenhagen C, Klein HU, Doan NB, Said JW, Mohith S, Gunasekar S, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Myklebost O, Yang H, Dugas M, Meza-Zepeda LA, Silberman AW, Forscher C, Tyner JW, Ogawa S, Koeffler HP (2015) Genomic Landscape of Liposarcoma. Oncotarget 6(40):42429–42444
Article PubMed Central PubMed Google Scholar
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011) DrugBank 3.0: a comprehensive resource for “omics” research on drugs. Nucleic Acids Res 39(Database issue):D1035-1041
Article CAS PubMed Google Scholar
Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G, Scully S, Elliott R, Grisanti M, Morony S, Tan HL, Asuncion F, Li X, Ominsky MS, Stolina M, Dwyer D, Dougall WC, Hawkins N, Boyle WJ, Simonet WS, Sullivan JK (2009) Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. J Bone Miner Res 24(2):182–195
留言 (0)